Table 1.

Baseline patient characteristics for 39 patients with localized prostate cancer. Data are presented as N (IQR) or % (N). IQR: interquartile range.

Demographics
	yr	(IQR)
Median age	61	(58–69)
Race	%	(N)
White	69	(27)
Black	15	(6)
Other	15	(6)
Clinical
	#	(IQR)
Median PSA (ng/ml)	9.56	(1.18–985.9)
Median PSA density	0.22	(0.15–0.39)
Median prostate volume (cc)	42.0	(33.0–49.0)
Median MRI tumor burden (cc)	3.47	(1.9–9.8)
Risk group	%	(N)
Intermediate	8	3
High	92	36
Histology
Pathologic stage	%	(N)
T2	15	(6)
T3a	44	(17)
T3b	28	(11)
T4	12	(5)
N1	28	(11)
Gleason score (Grade group)	%	(N)
3 + 4 (2)	15.4	(6)
4 + 3 (3)	12.8	(5)
4 + 4 (4)	28.2	(11)
4 + 5; 5 + 4; 5 + 5 (5)	46.6	(17)